[LXRX] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
01-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -29.89%
YoY- 48.19%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 37 27 7,999 9,216 25,207 18,293 12,494 -62.08%
PBT -23,476 -20,958 -66,611 -21,797 -42,075 -43,543 -34,883 -6.38%
Tax 96 48 958 789 6,119 -8,652 1,128 -33.66%
NP -23,572 -20,958 -66,611 -21,797 -42,075 -34,891 -34,883 -6.32%
Tax Rate - - - - - - - -
Total Cost 23,609 20,985 74,610 31,013 67,282 53,184 47,377 -10.95%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -63,708.11 -77,622.22 -832.74 -236.51 -166.92 -190.73 -279.20 147.09%
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -0.16 -0.15 -0.63 -0.21 -0.40 -0.33 -0.34 -11.80%
EPS Diluted -0.16 -0.15 -0.63 -0.21 -0.40 -0.33 -0.34 -11.80%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.